Seattle Flow Your front door to Seattle's startup scene.
Sign in
Stream Investors Events Founder Stack
  • Podcasts
  • Videos
  • Communities
  • Publications
Taylor Soper / GeekWire

Curi Bio raises $6M Series A led by Dynamk Capital to advance human stem cell drug-discovery platforms

Seattle stem-cell startup Curi Bio raised $6 million in a Series A led by Dynamk Capital to advance its human stem cell platforms for drug discovery, bringing total funding to $16.8 million.

C Curi Bio
  • Link
  • Report this item
  • Seattle Flow
  • LinkedIn
  • X
  • Threads
  • Bluesky
Replying to

No comments yet.

Seattle Flow — Your front door to Seattle's startup scene.

Run by Marcelo Calbucci M
About Manifesto Startup Day 2026 Send us a link Terms of Service Privacy For AI assistants Contact
© 2026 Seattle Flow, a service of The Fold. All rights reserved.

We love feedback!

Sign in or sign up to leave feedback

Who liked this

Edit history

Seattle Flow

Your front door to Seattle's startup scene.

Seattle's startup scene is scattered across a hundred feeds, newsletters, and calendars. Seattle Flow brings it together: the news, events, podcasts, and people, plus what the community is saying about them. Every link sends you to the source.

Writing about a Seattle founder, fund, or startup? We'll help it get seen. Found a great story we missed? Send it in.

We're in beta and building this with the community. Tell us what you want to see here.

Seattle's startup scene, every day. The news, events, podcasts, and people, plus what everyone's saying about them. We're in beta: send us a story or tell us what you want to see.